p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA

Biochemical Pharmacology

Volumn 63, Issue 5, 2002, Pages 871-880

  Kim, Seong Gon ^a   Ravi, Gnana ^a   Hoffmann, Carsten ^a   Jung, Yun Jin ^b   Kim, Min ^b   Chen, Aishe ^a   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adenosine receptor; Antagonist; APO 1; CD95; HL 60; MOLT 4; Phospholipase C; Poly ADP ribose polymerase

Indexed keywords

1 [2 CHLORO 6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] 1 DEOXY N METHYL BETA DEXTRO RIBOFURANONAMIDE; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; CALCIUM; CASPASE 3; DANTROLENE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FAS ANTIBODY; FAS ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE C; PROTEIN P53; PURINE P2Y RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; DRUG INTERACTIONS; HL-60 CELLS; HUMANS; LEUKEMIA; PHOSPHOLIPASE C; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036497307     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00839-0     Document Type: Article

References (42)

1. 3 receptors: Novel ligands and paradoxical effects
2. 3 adenosine receptors
3. 3-selective N-alkoxypurines as novel cytokine modulators and neuroprotectants
4. 3 receptors-pharmacological properties, species-differences and receptor functions
5. 3 receptor-mediated hypotension in the rat
6. 3 receptor activation in rats
7. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits
8. 3 receptor agonist and cerebral ischemia: Neuronal and glial effects
9. 3 receptor stimulation on seizures in mice
10. 3 receptor agonists
11. 3 antagonists
12. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells
13. 3 receptors and viability of astrocytes
14. 3 receptors
15. 3 adenosine receptor agonist
16. L: Studies in human astroglioma cells
17. 3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart
18. 3 adenosine receptor affects cell cycle progression and cell growth
19. 3 adenosine receptor antagonists
20. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries
21. 3 receptors in rat brain
22. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells
23. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion of antigen-stimulated RBL-2H3 cells
24. Fas antigen-mediated apoptosis in human granulosa-luteal cells
25. Receptors responsive to extracellular uracil nucleotides
26. 3 adenosine receptor activation and its suppression by isoproterenol
27. Ring-constrained (N)-methanocarba-nucleosides as adenosine receptor agonists: Independent 5′-uronamide and 2′-deoxy modifications
28. Activation of Akt/protein kinase B by G protein-coupled receptors. A role for α and βγ subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinase γ
29. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
30. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
31. Apoptosis and pathogenesis of viral hepatitis C - An update
32. Flow cytometric evaluation of Fas expression in relation to response and resistance to anthracyclines in leukemic cells
33. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis P.
34. Lack of correlation in JNK activation and p53-dependent Fas expression induced by apoptotic stimuli
35. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment
36. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
37. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines
38. Novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosis
39. Major deletions in the gene encoding the p53 tumor-antigen cause lack of p53 expression in HL-60 cells
40. p53 mutations in colorectal-cancer
41. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases
42. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia